Arbutus Biopharma Corp (NASDAQ:ABUS)

4.68
Delayed Data
As of Nov 21
 +0.23 / +5.17%
Today’s Change
4.01
Today|||52-Week Range
12.60
-7.33%
Year-to-Date

Today’s Trading

Previous close4.45
Today’s open4.52
Day’s range4.38 - 4.73
Volume171,660
Average volume (3 months)428,857
Market cap$246.9M
Data as of 4:00pm ET, 11/21/2018

Growth & Valuation

Earnings growth (last year)+78.45%
Earnings growth (this year)+29.17%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+617.64%
P/E ratioNM
Price/Sales25.83
Price/Book1.85

Competitors

 Today’s
change
Today’s
% change
ATHXAthersys Inc+0.11+5.85%
BDSIBioDelivery Sciences...+0.03+0.83%
ADROAduro Biotech Inc-0.23-7.54%
CNCEConcert Pharmaceutic...+0.18+1.45%
Data as of 4:00pm ET, 11/21/2018

Financials

Next reporting dateMarch 7, 2019
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$10.7M
Annual profit (last year)-$84.4M
Net profit margin-788.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer
David C. Hastings
Corporate headquarters
Burnaby, British Columbia

Forecasts